Goodwin advised Akero Therapeutics on the offering, and Cooley advised the underwriter involved. Akero Therapeutics (Nasdaq: AKRO) announced the closing of its underwritten registered direct offering...
Akero Therapeutics’s $220 Million Registered Direct Offering
iLearningEngines’ Merger with Arrowroot Acquisition Corp.
Goodwin advised Arrowroot Acquisition Corp. on the deal. Arrowroot Acquisition Corp. (NASDAQ:ARRW) announced its merger agreement with iLearningEngines. Upon closing of the transaction, the combined company will...
Sun Pharmaceutical’s $576 Million Acquisition of Concert Pharmaceuticals
Davis Polk advised Sun Pharmaceutical, and Goodwin Procter advised Concert Pharmaceuticals. Sun Pharmaceutical Industries Limited announced its acquisition of Concert Pharmaceuticals Inc., through a tender offer for an...
Circle’s Business Combination with Concord Acquisition Corp
Goodwin Procter and Matheson advised Circle on the deal. Arthur Cox and Greenberg Traurig advised Concord Acquisition Corp. Circle announced its definitive business combination agreement with Concord...
TPG Pace Tech Opportunities’ Business Combination With Nerdy
Vinson & Elkins LLP advised TPG Pace Tech Opportunities on the deal while Goodwin Procter LLP advised Nerdy Inc. on the deal. TPG Pace Tech Opportunities...